您的购物车当前为空
Midostaurin (PKC412) 是一种多靶点酪氨酸激酶抑制剂,有抗肿瘤活性,对 PKCα/β/γ、Syk、Flk-1、Akt、PKA、c-Kit、c-Fgr、c-Src、FLT3、PDFRβ和 VEGFR1/2 的 IC50 值范围为 22 到 500 nM 之间。Midostaurin 可用于急性髓系白血病(AML)与系统性肥大细胞增多症(SM)研究。
别名 米哚妥林, 苯甲酰基十字孢碱, PKC412, N-Benzoylstaurosporine, CGP41231, CGP 41251
Midostaurin (PKC412) 是一种多靶点酪氨酸激酶抑制剂,有抗肿瘤活性,对 PKCα/β/γ、Syk、Flk-1、Akt、PKA、c-Kit、c-Fgr、c-Src、FLT3、PDFRβ和 VEGFR1/2 的 IC50 值范围为 22 到 500 nM 之间。Midostaurin 可用于急性髓系白血病(AML)与系统性肥大细胞增多症(SM)研究。

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 627 | 现货 | |
| 5 mg | ¥ 1,490 | 现货 | |
| 10 mg | ¥ 2,380 | 现货 | |
| 25 mg | ¥ 3,750 | 现货 | |
| 50 mg | ¥ 5,330 | 现货 | |
| 100 mg | ¥ 7,290 | 现货 | |
| 200 mg | ¥ 9,850 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,870 | 现货 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | Midostaurin (PKC412) is a multi-targeted tyrosine kinase inhibitor with antitumor activity, exhibiting IC50 values ranging from 22 to 500 nM against PKCα/β/γ, Syk, Flk-1, Akt, PKA, c-Kit, c-Fgr, c-Src, FLT3, PDFRβ, and VEGFR1/2. Midostaurin is indicated for the treatment of acute myeloid leukemia (AML) and systemic mastocytosis (SM). |
| 靶点活性 | PKCβ2:31 nM, PKCβ1:30 nM, PPK:38 nM, p70 S6K:5000 nM, APKCζ:465 μM, FLK1:3900 nM, MLCK:1900 nM, nPKC-δ:33 nM, EGFR:1100 nM, PKCα:22 nM, CSK:8000 nM, PKA:570 nM, c-Src:800 nM, c-Lyn:4300 nM, Myosin light chain kinase:1900 nM, KDR:86 nM, nPKC-η:160 nM, mTOR (p70S6K):5000 nM, FLT1:912 nM, c-Syk:95 nM, CDK1-CyclinB:570 nM, PKCγ:24 nM, Protein kinase A:570 nM, nPKC-ε:1250 nM, c-Fgr:790 nM, CDK1-cyclinB:570 nM |
| 体外活性 | 方法:肥大细胞白血病细胞系 HMC-1.1,加入 Midostaurin(1 μM),处理 24-48 小时,TUNEL 染色检测细胞凋亡情况。 |
| 体内活性 | 方法:将 K562-FLT3 细胞皮下接种于免疫缺陷小鼠。待肿瘤可触及后,随机分组开始给药。Midostaurin 50 mg/kg,每日一次,口服灌胃。 Imatinib 50 mg/kg,每日两次,口服灌胃。联合治疗组同时给予上述剂量的 Midostaurin 和 Imatinib。 |
| 激酶实验 | Cells are plated overnight and treated with 100 nM AZD3965 or vehicle for 24 hours. The cells are then washed, once in PBS and twice with lysis buffer (50 mM Mops, 100 mM KCl, 5 mM MgCl2, 1 mM EDTA, 0.1 mM DTT, 1 mM PMSF supplemented with 1× mini complete protease inhibitor cocktail tablets. The cells are harvested by scraping and centrifugation, and the pellet snap frozen without buffer in liquid nitrogen. Frozen aliquots of cells are thawed on ice and re-suspended in lysis buffer. Cells are lysed by 3 rounds of freezing in liquid nitrogen and thawing at 37°C for 2 minutes each. Lysates are subsequently centrifuged (13000 g, 10min, 4°C) until clear and then stored on ice. Enzyme activity in the cell lysates is determined using a micro-plate reader to measure either production or depletion of NADH/NADPH, through its absorbance at 340/10 nm, occurring as a result of direct or coupled enzyme reactions. The 96 well plates used for the assays are pre-heated to 37°C for 10 minutes prior to starting reactions, initiated by the addition of 5 μL cell lysate to 95 μL of reaction buffer (50 mM Mops pH 7.4, 100 mM KCl, 5 mM free magnesium). The standard reaction buffer is supplemented to assay the kinetics of the different enzymes. Absorbance values for controls are subtracted from absorbance of corresponding reactions. Graphpad prism 6 is used to plot V0 values against substrate concentration and determine Vmax and Km values. The Vmax is then normalised to the protein concentration in the cell lysate[1]. |
| 细胞实验 | Each well is added with 5 mM WST-1 and 0.2 mM 1-methoxy PMS and the absorbance at 450 nm is measured by a Microplate Reader.(Only for Reference) |
| 别名 | 米哚妥林, 苯甲酰基十字孢碱, PKC412, N-Benzoylstaurosporine, CGP41231, CGP 41251 |
| 分子量 | 570.64 |
| 分子式 | C35H30N4O4 |
| CAS No. | 120685-11-2 |
| Smiles | COC1C(CC2OC1(C)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13)N(C)C(=O)c1ccccc1 |
| 密度 | 1.46g/cm3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 247.5 mg/mL (433.72 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (8.76 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。 | ||||||||||||||||||||||||||||||||||||
对于不同动物的给药剂量换算,您也可以参考 更多